Cargando…

A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30(+) lymphomas

CD30 is a 120‐kDa type I transmembrane glycoprotein belonging to the tumor necrosis factor receptor superfamily. Overexpression of CD30 has been reported in Hodgkin's lymphoma (HL) and anaplastic large‐cell lymphoma (ALCL). CD30‐targeted treatment with antibody–drug conjugates (ADCs) can lead t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rong, Li, Liang, Zhang, Shenghua, Li, Yi, Wang, Xiaofei, Miao, Qingfang, Zhen, Yongsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830626/ https://www.ncbi.nlm.nih.gov/pubmed/29316337 http://dx.doi.org/10.1002/1878-0261.12166

Ejemplares similares

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy
por: Xu, Jian, et al.
Publicado: (2015)

Cross-π-conjugated enediyne with multitopic metal binding sites
por: Nauroozi, Djawed, et al.
Publicado: (2020)

Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates
por: Adhikari, Ajeeth, et al.
Publicado: (2021)

Manipulation of pathway regulation in Streptomyces globisporus for overproduction of the enediyne antitumor antibiotic C-1027
por: Chen, Yihua, et al.
Publicado: (2010)

Alkoxy and Enediyne Derivatives Containing 1,4-Benzoquinone Subunits—Synthesis and Antitumor Activity
por: Kadela-Tomanek, Monika, et al.
Publicado: (2017)

A discrete intermediate for the biosynthesis of both the enediyne core and the anthraquinone moiety of enediyne natural products
por: Bhardwaj, Minakshi, et al.
Publicado: (2023)

Discovery of pentaene polyols by the activation of an enediyne gene cluster: biosynthetic implications for 9-membered enediyne core structures
por: Pan, Jian, et al.
Publicado: (2022)

An arginine-rich cell penetrating peptide contained anti-gelatinase scFv-LDM fusion protein shows potent antitumor efficacy in pancreatic cancer
por: Zhong, Genshen, et al.
Publicado: (2018)

An albumin-binding domain and targeting peptide-based recombinant protein and its enediyne-integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K-ras mutation
por: Sheng, Weijin, et al.
Publicado: (2020)

A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer
por: Guo, Xiao-Fang, et al.
Publicado: (2017)

An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer
por: Guo, Xiao-Fang, et al.
Publicado: (2014)

A superior drug carrier – aponeocarzinostatin in partially unfolded state fully protects the labile antitumor enediyne
por: Shanmuganathan, Aranganathan, et al.
Publicado: (2009)

Enediyne Polyketide Synthases Stereoselectively Reduce the β-Ketoacyl Intermediates to β-d-Hydroxyacyl Intermediates in Enediyne Core Biosynthesis
por: Ge, Hui-Ming, et al.
Publicado: (2014)

Strain Prioritization and Genome Mining for Enediyne Natural Products
por: Yan, Xiaohui, et al.
Publicado: (2016)

Correction for Bhardwaj et al., A discrete intermediate for the biosynthesis of both the enediyne core and the anthraquinone moiety of enediyne natural products
Publicado: (2023)

Thermal Reactivity of Neutral and Oxidized Ferrocenyl-Substituted Enediynes
por: Cinar, Mehmet Emin, et al.
Publicado: (2014)

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
por: Alvarez‐Fernández, Carmen, et al.
Publicado: (2021)

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
Publicado: (2022)

Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicity
por: Shen, Yijun, et al.
Publicado: (2019)

A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway
por: Gong, Jianhua, et al.
Publicado: (2018)

Highly selective cross-coupling reactions of 1,1-dibromoethylenes with alkynylaluminums for the synthesis of aryl substituted conjugated enediynes and unsymmetrical 1,3-diynes
por: Wu, Kun, et al.
Publicado: (2022)

Highly stereocontrolled synthesis of trans-enediynes via carbocupration of fluoroalkylated diynes
por: Konno, Tsutomu, et al.
Publicado: (2012)

Enediynes: Exploration of microbial genomics to discover new anticancer drug leads
por: Shen, Ben, et al.
Publicado: (2014)

Crystal Structure of SgcJ, An NTF2-Like Superfamily Protein Involved in Biosynthesis of the 9-Membered Enediyne Antitumor Antibiotic C-1027
por: Huang, Tingting, et al.
Publicado: (2016)

Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature
por: Delacruz, Wilfred, et al.
Publicado: (2016)

Site-specific PEGylation of lidamycin and its antitumor activity
por: Li, Liang, et al.
Publicado: (2015)

A dual role for a polyketide synthase in dynemicin enediyne and anthraquinone biosynthesis
por: Cohen, Douglas R., et al.
Publicado: (2017)

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
por: Xue, YuanBo, et al.
Publicado: (2021)

Jejucarbosides B–E, Chlorinated Cycloaromatized Enediynes, from a Marine Streptomyces sp.
por: Im, Ji Hyeon, et al.
Publicado: (2023)

Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients
por: Wang, D., et al.
Publicado: (2020)

Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013)

Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice
por: ZHU, BINGYAN, et al.
Publicado: (2016)

Cinchonain Ia Shows Promising Antitumor Effects in Combination with L-Asparaginase-Loaded Nanoliposomes
por: Nguyen, Thi Nga, et al.
Publicado: (2023)

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
por: Prince, H. Miles, et al.
Publicado: (2022)

Ruthenium-Catalyzed Intramolecular [2+2+2] Cycloaddition and Tandem Cross-Metathesis of Triynes and Enediynes
por: Yuan, Wei, et al.
Publicado: (2013)

Angle distortion model for predicting enediyne activation towards Bergman cyclization: an alternate to the distance theory
por: Bhattacharya, Prabuddha, et al.
Publicado: (2022)

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

Structure-Guided Functional Characterization of Enediyne Self-Sacrifice Resistance Proteins, CalU16 and CalU19
por: Elshahawi, Sherif I., et al.
Publicado: (2014)

A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer
por: He, Shiming, et al.
Publicado: (2022)

Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 production of Streptomyces globisporus C-1027
por: Wang, Lifei, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8n923purrqq9g82jmtmaf1m4q9